Antibodies to advanced glycation end products in children with diabetes mellitus

Author： Nicoloff G.   Baydanoff S.   Petrova C.   Christova P.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.39, Iss.1, 2002-07, pp. : 39-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus

By Menè P.   Festuccia F.   Pugliese F.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite

Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2096-2102

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W   Jenkins Alicia J   Cooper Mark E  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite

The Road to Advanced Glycation End Products: A Mechanistic Perspective

By  

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1653-1671

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Diabetic Neuropathy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 953-961

Bentham Science Publishers

Access to resources Recommend Favorite